- Trials with a EudraCT protocol (95)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (171)
95 result(s) found for: Iodine.
Displaying page 1 of 5.
EudraCT Number: 2005-002404-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-08-18 |
Sponsor Name:University of Dundee | ||
Full Title: A pilot study to inform a randomised controlled trial of iodine supplementation in preterm infants | ||
Medical condition: transient hypothyroxinaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003781-42 | Sponsor Protocol Number: 17465 | Start Date*: 2005-09-21 |
Sponsor Name:University of Dundee | ||
Full Title: | ||
Medical condition: Transient hypothyroxinanaemia | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001179-35 | Sponsor Protocol Number: SW2019-2 | Start Date*: 2019-09-20 |
Sponsor Name:St. Olavs Hospital | ||
Full Title: Optimizing preoperative disinfection before ocular surgery | ||
Medical condition: Bacterial eye infections | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004493-34 | Sponsor Protocol Number: 2017/06NOV/503 | Start Date*: 2018-01-02 |
Sponsor Name:Cliniques universitaires Saint-Luc | ||
Full Title: Evaluation of multiple subgingival irrigations with 10% povidone iodine after scaling and root planing : a randomized clinical trial | ||
Medical condition: Periodontitis is characterized by alveolar bone loss induced by the host immune response to bacterial insult. Because povidone iodine is known to be a powerful antiseptic, there is biologic rationa... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002437-37 | Sponsor Protocol Number: 13-1-033 | Start Date*: 2014-07-31 |
Sponsor Name:Maastricht University Medical Centre | ||
Full Title: Effects on Intra-Coronary Attenuation using low iodine concentrations (240 mg, 300 mg and 370 mg iodine per ml) while maintaining identical IDR | ||
Medical condition: atypical or typical complaints of angina pectoris with no previous cardiovascular medical history low to intermediate risk for atherosclerosis referred for coronary CTA to rule out CAD | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003687-37 | Sponsor Protocol Number: BRD/05/83 | Start Date*: 2006-07-24 |
Sponsor Name:University College London | ||
Full Title: HiLo: Multicentre randomised phase III clinical trial of high versus low dose radioiodine, with or without recombinant human thyroid stimulating hormone (rhTSH), for remnant ablation following surg... | ||
Medical condition: Differentiated thyroid cancer (DTC) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012007-25 | Sponsor Protocol Number: BAY43-9006/14295 | Start Date*: 2009-10-21 | |||||||||||||||||||||
Sponsor Name:Bayer AG | |||||||||||||||||||||||
Full Title: A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer | |||||||||||||||||||||||
Medical condition: Differentiated thyroid cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) GB (Completed) ES (Completed) IT (Completed) NL (Completed) FR (Completed) DK (Completed) SE (Completed) BE (Completed) AT (Completed) SK (Completed) BG (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-016566-82 | Sponsor Protocol Number: 05/SP/120 | Start Date*: 2009-12-29 |
Sponsor Name:Belfast Health and Social Care Trust [...] | ||
Full Title: Skin bacteria as a source of surgical infections: molecular epidemiology and prevention of wound contaimination | ||
Medical condition: No medical condition under investigation, investigation of surgical wound contamination in spinal patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000694-24 | Sponsor Protocol Number: X-00069-3322 | Start Date*: 2020-02-03 |
Sponsor Name:Meda Pharma GmbH & Co. KG (A Mylan company) | ||
Full Title: Evaluation of the antiseptic activity of 4 different modes of application of a 5% alcoholic povidone-iodine product (Bétadine® Alcoolique 5%) | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001852-16 | Sponsor Protocol Number: 01-04-2020 | Start Date*: 2020-07-14 | |||||||||||
Sponsor Name:Maxima MC | |||||||||||||
Full Title: Effect of Iodine treatment in patiënts with COVID-19 disease | |||||||||||||
Medical condition: SARS-CoV-2 infection causing COVID-19 disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-006052-37 | Sponsor Protocol Number: IOM/BRA/035 | Start Date*: 2006-04-13 |
Sponsor Name:Bracco ALTANA Pharma GmbH | ||
Full Title: COMPARISON OF IOMEPROL 300 AND IOMEPROL 400 FOR THE EFFICIENCY OF AUTOSEGMENTATION IN 64-ROW MULTI-DETECTOR CTA OF THE CORONARY ARTERIES | ||
Medical condition: Indication for coronary multi-detector computed tomographic angiography | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000675-15 | Sponsor Protocol Number: 06RP02 | Start Date*: 2006-09-11 |
Sponsor Name:Great Ormond Street Hospital for Children NHS Trust | ||
Full Title: Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous a... | ||
Medical condition: Potential Systematic Sepsis | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004221-32 | Sponsor Protocol Number: 2017PG2 | Start Date*: 2018-08-06 |
Sponsor Name:Department of Anesthesia Reanimation of University of Liege | ||
Full Title: Mechanism of action of the quadratus lumborum block | ||
Medical condition: Patients undergoing abdominal laparoscopy or laparotomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-000574-19 | Sponsor Protocol Number: LT4RAIT | Start Date*: 2014-03-24 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI PARMA | |||||||||||||
Full Title: Experimental study for the evaluation of the effect of radioactive iodine therapy on free thyroxine circulating levels after oral administration of sodium levo-thyroxine in patients thyroidectomiz... | |||||||||||||
Medical condition: patients thyroidectomized for differentiated thyroid cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000456-19 | Sponsor Protocol Number: BC-09501 | Start Date*: 2021-11-17 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Use of 18F-PSMA-11 PET for detection of lesions in iodine refractory thyroid cancers | ||
Medical condition: Patients with a iodine refractory thyroid carcinoma, who received an 18F -FDG PET/CT scan in routine clinical practice. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003194-24 | Sponsor Protocol Number: CPI-226-03 | Start Date*: 2006-01-02 |
Sponsor Name:Cadence Pharmaceuticals, Inc. | ||
Full Title: Estudio en fase III, multicéntrico, aleatorizado, con enmascaramiento del tratamiento para el comité de evaluación para valorar la eficacia de la administración tópica de omiganán al 1,0% en gel en... | ||
Medical condition: Prevención de infecciones en la zona del catéter. Prevention of local site infections in patients requiring central venous and/or arterial catheterization and/or peripherally inserted central veno... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002941-49 | Sponsor Protocol Number: ERRITI | Start Date*: 2017-01-31 |
Sponsor Name:University Hospital Essen (Anstalt des öffentlichen Rechts) | ||
Full Title: Enhancing Radioiodine Incorporation into Radio Iodine Refractory Thyroid Cancers with MAPK Inhibition: A single center pilot study | ||
Medical condition: Radio Iodine Refractory Thyroid Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001721-31 | Sponsor Protocol Number: SPON-AK-0420 | Start Date*: 2020-05-01 | |||||||||||
Sponsor Name:Hampshire Hospitals NHS TRust | |||||||||||||
Full Title: Can a sinus rinse and mouth wash reduce viral load in COVID-19 positive individuals? | |||||||||||||
Medical condition: Covid-19 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004811-22 | Sponsor Protocol Number: ABR 14357 | Start Date*: 2008-04-01 | |||||||||||
Sponsor Name:Erasmus Medical Center Rotterdam | |||||||||||||
Full Title: A prospective, randomized, double-blind comparison of 5 % against 1 % povidone-iodine solution in preoperative antisepsis for strabismus surgery in young children. | |||||||||||||
Medical condition: Endophthalmitis (E) after strabismus surgery (S) leading to blindness is caused by eyelid and conjunctival bacteria. Povidone-iodine(PI) solutions between 1% and 5% reduce the number of bacteria on... | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000423-14 | Sponsor Protocol Number: D1532C00065 | Start Date*: 2013-05-23 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Diff... | ||
Medical condition: Differentiated Thyroid Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) DE (Completed) IT (Completed) FR (Completed) DK (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
